MARVEL DISCOVERY CORP (MARV.CA) Fundamental Analysis & Valuation

TSX-V:MARV • CA57383V1085

Current stock price

0.03 CAD
0 (0%)
Last:

This MARV.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MARV.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MARV has reported negative net income.
  • In the past year MARV has reported a negative cash flow from operations.
  • In the past 5 years MARV always reported negative net income.
  • MARV had a negative operating cash flow in each of the past 5 years.
MARV.CA Yearly Net Income VS EBIT VS OCF VS FCFMARV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -500K -1M -1.5M -2M

1.2 Ratios

  • The Return On Assets of MARV (-20.63%) is comparable to the rest of the industry.
  • With a Return On Equity value of -27.76%, MARV perfoms like the industry average, outperforming 52.07% of the companies in the same industry.
Industry RankSector Rank
ROA -20.63%
ROE -27.76%
ROIC N/A
ROA(3y)-25.78%
ROA(5y)-21.56%
ROE(3y)-34.73%
ROE(5y)-29.39%
ROIC(3y)N/A
ROIC(5y)N/A
MARV.CA Yearly ROA, ROE, ROICMARV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

  • MARV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MARV.CA Yearly Profit, Operating, Gross MarginsMARV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MARV.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, MARV has more shares outstanding
  • MARV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MARV.CA Yearly Shares OutstandingMARV.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
MARV.CA Yearly Total Debt VS Total AssetsMARV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

2.2 Solvency

  • Based on the Altman-Z score of -2.38, we must say that MARV is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -2.38, MARV perfoms like the industry average, outperforming 40.15% of the companies in the same industry.
  • MARV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.38
ROIC/WACCN/A
WACCN/A
MARV.CA Yearly LT Debt VS Equity VS FCFMARV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

  • MARV has a Current Ratio of 0.29. This is a bad value and indicates that MARV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MARV has a worse Current ratio (0.29) than 72.38% of its industry peers.
  • A Quick Ratio of 0.29 indicates that MARV may have some problems paying its short term obligations.
  • MARV has a worse Quick ratio (0.29) than 71.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
MARV.CA Yearly Current Assets VS Current LiabilitesMARV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. MARV.CA Growth Analysis

3.1 Past

  • MARV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -173.33%.
EPS 1Y (TTM)-173.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1500%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. MARV.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • MARV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MARV.CA Price Earnings VS Forward Price EarningsMARV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MARV.CA Per share dataMARV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MARV.CA Dividend Analysis

5.1 Amount

  • MARV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MARV.CA Fundamentals: All Metrics, Ratios and Statistics

MARVEL DISCOVERY CORP

TSX-V:MARV (3/4/2025, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-21
Earnings (Next)04-28
Inst Owners9.54%
Inst Owner ChangeN/A
Ins Owners8.73%
Ins Owner ChangeN/A
Market Cap4.41M
Revenue(TTM)N/A
Net Income(TTM)-1.25M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.63%
ROE -27.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-25.78%
ROA(5y)-21.56%
ROE(3y)-34.73%
ROE(5y)-29.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -2.38
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-173.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1500%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.13%
OCF growth 3YN/A
OCF growth 5YN/A

MARVEL DISCOVERY CORP / MARV.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MARVEL DISCOVERY CORP (MARV.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to MARV.CA.


What is the valuation status for MARV stock?

ChartMill assigns a valuation rating of 0 / 10 to MARVEL DISCOVERY CORP (MARV.CA). This can be considered as Overvalued.


What is the profitability of MARV stock?

MARVEL DISCOVERY CORP (MARV.CA) has a profitability rating of 1 / 10.